Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD44 expression predicts local recurrence after radiotherapy in larynx cancer.
de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, Takes RP, Kaanders JH, van der Laan BF, Wachters J, Jansen JC, Rasch CR, van Velthuysen ML, Grénman R, Hoebers FJ, Schuuring E, van den Brekel MW, Begg AC. de Jong MC, et al. Among authors: de jong jm. Clin Cancer Res. 2010 Nov 1;16(21):5329-38. doi: 10.1158/1078-0432.CCR-10-0799. Epub 2010 Sep 13. Clin Cancer Res. 2010. PMID: 20837694
Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients.
Egelmeer AG, Velazquez ER, de Jong JM, Oberije C, Geussens Y, Nuyts S, Kremer B, Rietveld D, Leemans CR, de Jong MC, Rasch C, Hoebers F, Homer J, Slevin N, West C, Lambin P. Egelmeer AG, et al. Among authors: de jong jm, de jong mc. Radiother Oncol. 2011 Jul;100(1):108-15. doi: 10.1016/j.radonc.2011.06.023. Epub 2011 Jul 23. Radiother Oncol. 2011. PMID: 21784544 Free article.
Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas.
van Agthoven M, Heule-Dieleman HA, de Boer MF, Kaanders JH, Baatenburg de Jong RJ, Kremer B, Leemans CR, Marres HA, Manni JJ, Langendijk JA, Levendag PC, Tjho-Heslinga RE, de Jong JM, Uyl-de Groot CA, Knegt PP. van Agthoven M, et al. Among authors: de boer mf, de jong jm. Radiother Oncol. 2005 Mar;74(3):337-44. doi: 10.1016/j.radonc.2005.01.003. Radiother Oncol. 2005. PMID: 15763316
Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas.
van Agthoven M, Heule-Dieleman HA, Knegt PP, Kaanders JH, Baatenburg de Jong RJ, Kremer B, Leemans CR, Marres HA, Manni JJ, Langendijk JA, Levendag PC, Tjho-Heslinga RE, de Jong JM, de Boer MF, Uyl-de Groot CA. van Agthoven M, et al. Among authors: de boer mf, de jong jm. Eur Arch Otorhinolaryngol. 2006 Aug;263(8):729-37. doi: 10.1007/s00405-006-0062-6. Epub 2006 May 14. Eur Arch Otorhinolaryngol. 2006. PMID: 16699832
Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA, Tjho-Heslinga RE, de Jong JM, Roodenburg JL; Dutch Head and Neck Oncology Cooperative Group. Terhaard CH, et al. Among authors: de jong jm. Head Neck. 2004 Aug;26(8):681-92; discussion 692-3. doi: 10.1002/hed.10400. Head Neck. 2004. PMID: 15287035
142 results